Quantifying rate-limiting genetic variation in breast and ovarian tumourigenesis
NIH/NCI (P30CA016042; 1U01CA214194-01), NIH NIGMS (R35GM138113, 2R35GM138113), ACS (RSG-22-115-01-DMC), CIHR Vanier Fellowship, and the Francis Crick Institute with core funding from Cancer Research UK, UK Medical Research Council, and Wellcome Trust.
Authors
- Daniel Jeremy Fulop
- Gonzalo López (ORCID: https://orcid.org/0000-0002-5092-1284)
- Marc Williams (ORCID: https://orcid.org/0000-0001-5524-4174)
- Peter Van Loo
- J Contreras
- Mahad Bihie
- Paul C. Boutros
- Kuan-lin Huang
- Hsin-Hsiung Huang
- Kathleen E. Houlahan
- Yves Greatti
Institutions
- University of Central Florida (US)
- Memorial Sloan Kettering Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Johns Hopkins University (US)
- University of California, Los Angeles (US)
- The Francis Crick Institute (GB)
- University of Colorado Anschutz Medical Campus (US)
- McMaster University (CA)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- EBioMedicine
- Published
- 2026-02-21
- DOI
- https://doi.org/10.1016/j.ebiom.2026.106181
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00